Expert Interviews

The 2026 meeting emphasized integrating cutting-edge medical therapies with aesthetic strategies to address both disease control and quality of life.

LILAC data shows litifilimab rapidly improves CLE skin scores, fueling AMETHYST phase 3 and supporting FDA breakthrough for cutaneous lupus patients.

Todd Schlesinger, MD, reviews emerging randomized trial data supporting red light–activated photodynamic therapy with 10% aminolevulinic acid gel and outlines key considerations for patient selection in superficial basal cell carcinoma (sBCC).

Experts discuss effective strategies for managing atopic dermatitis, emphasizing the importance of treatment adherence and quality of life improvements.

Explore effective management strategies for pediatric atopic dermatitis, focusing on treatment options and patient experiences for optimal care.

Todd Schlesinger, MD, discusses emerging evidence, clearance outcomes, and practical considerations for using red light–based photodynamic therapy as a nonsurgical option in select superficial basal cell carcinoma (BCC) cases.

Victoria Werth, MD, highlights CLE treatment gaps and how BDCA2-targeting litifilimab may quickly curb interferon-driven skin disease with less toxicity.

Achieving lower psoriasis levels significantly enhances patients' emotional well-being and overall quality of life, transforming their daily experiences.

Healthcare providers discuss effective communication strategies for explaining treatment goals to patients, emphasizing collaboration and understanding in managing chronic conditions.

Bispecific and trispecific biologics are being developed to achieve deeper clearance and more meaningful symptom relief.

Clinicians are increasingly facing barriers when attempting to prescribe on-label treatments for indicated patients.

At South Beach Symposium 2026, Mona Shahriari explores OX40/OX40L therapies for atopic dermatitis.

Glynis Ablon, MD, FAAD, examines the intersection of menopause, hormones, and dermatologic health.

At MOPD 2026, Lisa Swanson, MD, urges fungal cultures amid terbinafine resistance and warns attendees about risky kids’ skin care trends.

At South Beach Symposium 2026, Benjamin Ungar, MD, discussed safer, long-term approaches for seborrheic dermatitis.

Glynis Ablon, MD, FAAD, shares insights on diagnosing alopecia fast, managing aesthetic complications, and choosing evidence-based supplements.

David Cotter, MD, PhD, underscored the importance of incorporating quality-of-life and mental health measures into psoriasis clinical trials.

At MOPD 2026, Kristina Derrick, MD, ScM, links teen acne to hormones and metabolism, highlighting PCOS clues and antiandrogen therapies.

Parents of children with chronic skin conditions seek guidance on managing flares and long-term treatment strategies for better outcomes.

Experts discuss effective eczema management for young children, emphasizing treatment options, parental education, and the importance of long-term care strategies.

James Del Rosso, DO, discusses diagnosis and treatment of mastocytosis and inflammatory conditions.

Discover effective strategies for addressing patients' "I'm fine" responses and uncovering hidden health concerns through guided questions and assessments.

Explore the evolving concept of on-treatment remission in psoriasis management and its impact on patient care and quality of life.

Jennelle Daly, PA-C, explores the integration of aesthetic dermatology and wellness, emphasizing holistic approaches for optimal skin health and patient outcomes.

Galderma's Bill Andriopoulos, PhD, discusses Dysport's real-world success and evolving trends in aesthetic injectables, emphasizing patient satisfaction and innovative treatments.

James Del Rosso, DO, discusses innovative therapies for chronic hand eczema (CHE), chronic spontaneous urticaria (CSU), and vitiligo.

Discover insights from Bill Andriopoulos, PhD, on Relfydess, a groundbreaking neuromodulator utilizing PEARL Technology for enhanced efficacy and safety.

Explore the importance of high-energy visible (HEV) blue light protection, especially post procedures, and discover effective patient strategies for managing melasma and skin health.

A pediatric case highlights the challenges of managing severe atopic dermatitis in infants, emphasizing the need for effective treatment strategies.

An 18-month-old with severe atopic dermatitis experiences rapid flare-ups, prompting a discussion on treatment options and potential triggers.